Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
Current Value
$13.521 Year Return
Current Value
$13.521 Year Return
Market Cap
$1.16B
P/E Ratio
23.55
1Y Stock Return
-58.40%
1Y Revenue Growth
10.24%
Dividend Yield
0.00%
Price to Book
2.8
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PULM | -20.04% | $19.83M | +202.98% | 0.00% |
TXO | -18.61% | $737.26M | -1.80% | 13.22% |
EWTX | -18.23% | $2.98B | +397.00% | 0.00% |
AXON | -17.13% | $46.53B | +167.14% | 0.00% |
HUSA | -14.76% | $16.69M | -11.56% | 0.00% |
ACMR | -13.57% | $1.15B | +5.14% | 0.00% |
BWXT | -13.20% | $11.92B | +67.39% | 0.91% |
SU | -13.07% | $52.05B | +23.58% | 3.92% |
GAN | -12.78% | $83.39M | +21.19% | 0.00% |
MNSO | -12.44% | $5.45B | -28.63% | 1.56% |
STG | -12.10% | $35.67M | +7.92% | 0.00% |
FTNT | -12.05% | $69.59B | +72.67% | 0.00% |
LPLA | -11.21% | $23.55B | +38.13% | 0.38% |
CARV | -10.97% | $8.48M | -8.79% | 0.00% |
DOGZ | -10.66% | $614.77M | +1,372.26% | 0.00% |
HIHO | -10.52% | $8.63M | 0.00% | 6.12% |
SCKT | -10.34% | $10.88M | +15.32% | 0.00% |
TPB | -9.78% | $1.08B | +167.44% | 0.45% |
FRO | -9.17% | $4.56B | -7.37% | 9.36% |
CEG | -8.70% | $73.37B | +91.48% | 0.59% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NVRO | 39.58% | $158.88M | -73.60% | 0.00% |
SCS | 36.60% | $1.49B | +8.36% | 3.06% |
KSPI | 36.54% | $20.86B | +18.06% | 3.37% |
ZIP | 36.44% | $853.92M | -30.91% | 0.00% |
ODP | 34.72% | $777.35M | -46.62% | 0.00% |
CRMT | 34.42% | $337.96M | -46.71% | 0.00% |
EYE | 34.29% | $888.30M | -42.18% | 0.00% |
XNCR | 34.17% | $1.65B | +27.73% | 0.00% |
SHEN | 33.71% | $698.36M | -44.66% | 0.79% |
MVIS | 33.58% | $198.19M | -60.14% | 0.00% |
SGC | 32.76% | $261.95M | +41.61% | 4.32% |
PSFE | 32.74% | $1.06B | +42.18% | 0.00% |
HNST | 32.36% | $739.03M | +360.38% | 0.00% |
IMXI | 32.34% | $651.21M | -1.55% | 0.00% |
TDOC | 32.31% | $1.54B | -47.22% | 0.00% |
CARS | 32.21% | $1.20B | -2.01% | 0.00% |
JBI | 31.85% | $1.00B | -31.76% | 0.00% |
SEAT | 31.74% | $478.73M | -52.29% | 0.00% |
CNDT | 31.61% | $569.21M | +20.27% | 0.00% |
EB | 31.01% | $341.99M | -48.62% | 0.00% |
Yahoo
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The third quarter had a strong finish for U.S. small-cap equities, driven by interest rate reductions and fading recessionary concerns. In the third quarter, the fund delivered 7.65% […]
SeekingAlpha
Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.
SeekingAlpha
Progyny's Q3 2024 financials show minimal revenue growth, declining margins, and lower earnings per share. Read why I have sold my PGNY shares.
Yahoo
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 8:00 a.m. GMT (3:00 a.m. EST). A live audiocast and replay will be available from the Events and Presentations
Yahoo
Progyny ( NASDAQ:PGNY ) Third Quarter 2024 Results Key Financial Results Revenue: US$286.6m (up 2.0% from 3Q 2023). Net...
Yahoo
BofA lowered the firm’s price target on Progyny (PGNY) to $21 from $22 and keeps a Buy rating on the shares. Q3 results highlight ongoing pressure from an unfavorable utilization mix, with limited line of sight into when such dynamics may change, but while the firm acknowledges that utilization trends create some uncertainty, overall it remains optimistic on the fertility end-market and Progyny’s market leading position, the analyst tells investors. Published first on TheFly – the ultimate sourc
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PENG | -0.01% | $911.79M | +4.97% | 0.00% |
BELFB | -0.02% | $903.17M | +35.81% | 0.38% |
XBIO | -0.04% | $6.01M | +21.36% | 0.00% |
IMO | -0.04% | $39.72B | +31.84% | 2.23% |
EXPD | 0.06% | $16.52B | +0.14% | 1.20% |
ASX | 0.06% | $21.39B | +14.92% | 3.25% |
TLPH | -0.07% | $11.41M | +9.85% | 0.00% |
MNR | 0.07% | $1.66B | -10.71% | 15.90% |
CNQ | 0.08% | $71.04B | +1.89% | 6.81% |
PCRX | -0.10% | $772.48M | -37.25% | 0.00% |
AEG | 0.11% | $10.23B | +18.32% | 5.54% |
NTIC | -0.12% | $132.27M | +24.98% | 2.02% |
CMG | 0.14% | $80.02B | +33.62% | 0.00% |
NVT | -0.15% | $12.45B | +40.88% | 1.00% |
PGR | 0.18% | $149.10B | +57.29% | 0.45% |
AGX | -0.20% | $2.01B | +224.91% | 0.85% |
BAH | -0.23% | $17.62B | +9.13% | 1.47% |
PRT | -0.24% | $48.72M | -16.56% | 10.33% |
ROAD | 0.24% | $4.91B | +118.93% | 0.00% |
GL | -0.25% | $9.18B | -8.60% | 0.86% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -18.29% | $388.04M | 1.43% |
DBO | -15.16% | $217.57M | 0.77% |
DBE | -14.95% | $50.13M | 0.77% |
VIXY | -14.21% | $195.31M | 0.85% |
ULST | -12.04% | $535.47M | 0.2% |
EQLS | -12.04% | $76.08M | 1% |
GSG | -11.60% | $914.42M | 0.75% |
PDBC | -11.48% | $4.40B | 0.59% |
COMT | -10.90% | $829.06M | 0.48% |
DBC | -10.52% | $1.39B | 0.87% |
PREF | -9.56% | $999.92M | 0.55% |
UUP | -9.38% | $309.25M | 0.77% |
USDU | -8.14% | $201.97M | 0.5% |
HIGH | -7.73% | $302.78M | 0.51% |
TAIL | -7.71% | $67.98M | 0.59% |
CTA | -6.54% | $350.27M | 0.78% |
AGZD | -6.12% | $142.76M | 0.23% |
KCCA | -5.43% | $220.51M | 0.87% |
UNG | -4.26% | $908.80M | 1.06% |
BCI | -3.45% | $1.20B | 0.26% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IWC | 32.56% | $933.99M | 0.6% |
XSLV | 31.03% | $322.27M | 0.25% |
IHF | 30.71% | $703.90M | 0.4% |
SMMV | 30.56% | $321.07M | 0.2% |
XTN | 30.54% | $266.48M | 0.35% |
PRFZ | 30.40% | $2.65B | 0.39% |
RYLD | 30.40% | $1.45B | 0.6% |
PBW | 30.33% | $301.18M | 0.65% |
RSPD | 30.26% | $298.43M | 0.4% |
RWJ | 30.05% | $1.75B | 0.39% |
RZV | 29.94% | $258.76M | 0.35% |
IWM | 29.87% | $75.73B | 0.19% |
XRT | 29.85% | $451.85M | 0.35% |
CALF | 29.85% | $8.93B | 0.59% |
FXH | 29.83% | $1.15B | 0.62% |
IWN | 29.73% | $13.17B | 0.24% |
DES | 29.64% | $2.13B | 0.38% |
VIOO | 29.62% | $3.12B | 0.1% |
VTWO | 29.59% | $12.38B | 0.1% |
DFAT | 29.51% | $11.16B | 0.28% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PFFR | -0.16% | $112.85M | 0.45% |
GCC | 0.21% | $133.23M | 0.55% |
KMLM | -0.22% | $353.87M | 0.9% |
BOXX | 0.46% | $4.43B | 0.1949% |
SMH | 0.53% | $23.66B | 0.35% |
CMDY | -0.69% | $279.14M | 0.28% |
CORN | -0.89% | $61.12M | 0.2% |
BCD | -1.06% | $245.02M | 0.3% |
AMDY | -1.29% | $144.24M | 0.99% |
HDRO | -1.38% | $164.26M | 0.3% |
KRBN | 1.43% | $242.47M | 0.85% |
DBMF | -1.44% | $1.02B | 0.85% |
CANE | -1.63% | $17.72M | 0.29% |
FBY | 1.68% | $127.69M | 0.99% |
USCI | -2.00% | $185.47M | 1.07% |
FLTR | -2.08% | $1.79B | 0.14% |
HEWJ | 2.08% | $347.32M | 0.5% |
FMF | -2.08% | $244.61M | 0.95% |
WEAT | 2.10% | $120.27M | 0.28% |
SOYB | 2.15% | $27.32M | 0.22% |